Atlas Trials

Mechanisms of Sulforaphane Supplementation in Alleviating Negative Symptoms and Cognitive Impairment in Schizophrenia

Clinical trial NCT07652866 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07652866
Sponsor
Second Xiangya Hospital of Central South University
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Schizophrenia Disorder
Start date
2026-06-02
Primary completion
2028-12-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.